$CCEP

Transactions in Own Shares

Coca-Cola Europacific Partners (CCEP) said it bought back its own ordinary shares from 10 Aug 2026 to 14 Aug 2026. It repurchased 155,000 shares on US trading venues and 62,456 on London venues, with prices ranging about USD 104.6 to 108.16 and GBP 77.45 to 79.7. Shares will be cancelled under its EUR 1 billion buyback programme.

Original reporting
Published Aug 17, 2026, 3:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 17, 2026, 3:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Transactions in Own Shares — source image
Decision brief

The 30-second read

$CCEPNeutralLow
01

Why it matters

This is an execution report of repurchases to be cancelled, which can provide mild support to per-share metrics and sentiment but typically has limited immediate price impact without changes to guidance, authorization size, or financing terms.

02

Market read

Routine buyback tranche disclosure with no new program parameters; relevance is mainly for tracking capital return pace.

03

What to watch

Traders may want to compare repurchase pace versus prior tranches and assess whether the buyback is funded by excess cash or leverage, neither of which is addressed here.

Relevance 4/10Novelty 3/10Timing: buyback execution update covering 10-14 Aug 2026

Background

The company states the purchases are part of a share buyback programme announced 17 Feb 2026, targeting up to EUR 1 billion of ordinary shares.

Company-level read

Ticker impact

$CCEPNeutralHigh confidence
Context

Coca-Cola Europacific Partners reports it bought back 155,000 ordinary shares on US venues and 62,456 on London venues, to be cancelled.

Expected impact

Likely limited near-term impact; any effect should be small versus broader market moves.

Evidence & confidence

The disclosure is a standard issuer share repurchase update tied to an already-announced EUR 1 billion buyback program, with no new financial targets or operational/regulatory developments.

Market effects

Adds incremental evidence of ongoing capital return in large consumer staples, but does not change sector fundamentals.

Primarily UK/EU listed capital return optics; minimal spillover to broader regional risk.

No direct global macro or supply-chain linkage beyond routine buyback activity.

Counterpoint

Buybacks can be offset by dilution elsewhere or by weaker underlying cash generation; this update alone does not confirm improved fundamentals.

Key entities

  • Coca-Cola Europacific Partners

    Announces share repurchases from 10 Aug 2026 through 14 Aug 2026 across US and London trading venues, to be cancelled.

  • Goldman Sachs

    Named as the broker/agent for the repurchases on both US and London trading venues.

Related articles

$CCEPMedAI 8/10

CCEP (CCEP) Q2 2026 Earnings Call Transcript

Coca-Cola Europacific Partners (CCEP) reported Q2 2026 results on a half-year basis: revenue EUR 10.7B (+6.1%), operating profit EUR 1.5B (+8.1%), operating margin 13.8% (+30 bps), and diluted EPS EUR 2.20 (+10.6%). Free cash flow was EUR 435M in H1; management reaffirmed full-year FCF target of at least EUR 1.7B and completed EUR 600M of a EUR 1B buyback. Risks include Middle East commodity volatility.

$CCEPMed

Coca-Cola Europacific Partners PLC Q2 2026 Earnings Call Summary

Coca-Cola Europacific Partners (CCEP) reported Q2 2026 results driven by volume growth and positive revenue per case, with Zero Sugar, Energy and Sports outperforming. Management cited FIFA World Cup activations, margin expansion of 30 bps, and reaffirmed full-year 2026 guidance despite 6 fewer trading days. Capex includes a Manila greenfield site in 2027 and cooler placements.

$CCEPMedAI 8/10

Revenue Tops €10.7bn In Coca-Cola Europacific Partners’ H1

Coca-Cola Europacific Partners (CCEP) reported H1 2026 revenue of €10.7bn, up 4.4% reported and 6.1% FX neutral. Operating profit was €1.46bn reported (+6.9%) and profit after tax €991m (+5.8%). Total volume rose to 2,041m unit cases (+5.6%). Full-year guidance calls for ~3-4% revenue and ~7% operating profit growth.

$CCEPMedAI 8/10

CCEP (CCEP) Q2 2026 Earnings Call Transcript

Coca-Cola Europacific Partners (CCEP) reported first-half 2026 results on an earnings call. Revenue rose 6.1% to EUR 10.7B, operating profit increased 8.1% to EUR 1.5B, and diluted EPS rose 10.6% to EUR 2.20. Free cash flow was EUR 435M, with full-year guidance reaffirmed and EUR 600M of a EUR 1B buyback completed.

$CCEPMed

Coca-Cola Europacific shares lose fizz after interim results

Coca-Cola Europacific Partners reported higher first-half profit and reaffirmed 2026 guidance, but shares fell 4.3% to 7,710p after interim results. Revenue rose 4.4% to €10.7bn, operating profit increased 6.9% to €1.5bn, and diluted EPS grew 9.1% to €2.17. Guidance: currency-neutral revenue growth 3% to 4%, operating profit growth around 7%, free cash flow at least €1.7bn.